EIM
MNTA

Essex Investment Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Essex Investment Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-12,533
Closed -$330K – 556
2018
Q3 		$330K Buy
+12,533
New +$339K 0.04% 339

Other funds holding MNTA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Essex Investment Management's MNTA Position: Q4 2018 in Review

Essex Investment Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2018, closing a stake of 12,533 shares — an estimated $330K sold.

Essex Investment Management first reported a position in MNTA in Q3 2018 and held it in 1 quarter. The position peaked at $330K in Q3 2018. 158 funds tracked by Wall St. Rank hold MNTA as of Q4 2018.

  • Essex Investment Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Essex Investment Management sold 12,533 Momenta Pharmaceuticals, Inc. shares in Q4 2018, an estimated $330K.
  • Essex Investment Management first reported a position in Momenta Pharmaceuticals, Inc. in Q3 2018 and held it in 1 quarter.
  • Essex Investment Management's Momenta Pharmaceuticals, Inc. position peaked at $330K in Q3 2018.
  • 158 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2018.

Based on Essex Investment Management's 13F filing for Q4 2018, filed 6 Feb 2019.